Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway

Cancer Cell

Volumn 7, Issue 6, 2005, Pages 575-589

  Lo, Hui Wen ^a   Hsu, Sheng Chieh ^a   Ali Seyed, Mohamed ^a   Gunduz, Mehmet ^a   Xia, Weiya ^a   Wei, Yongkun ^a   Bartholomeusz, Geoffrey ^a   Shih, Jin Yuan ^a   Hung, Mien Chie ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYL IMIDAZOLIN 1 OXYL 3 OXIDE; 2 PHENYL 4,4,5,5 TETRAMETHYLIMIDAZOLIN 1 OXYL 3 OXIDE; 4 (3 BROMOANILINO) 6 (METHYLAMINO)PYRIDO[3,4 D]PYRIMIDINE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; INDUCIBLE NITRIC OXIDE SYNTHASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; S METHYLPSEUDOTHIOUREA; SCAVENGER; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DEREGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

EID: 20444423286     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.05.007     Document Type: Article

References (82)

1. J. Albanell, F. Rojo, and J. Baselga Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 Semin. Oncol. 28 2001 56 66
2. D. Anderson, C.A. Koch, L. Grey, C. Ellis, M.F. Moran, and T. Pawson Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors Science 250 1990 979 982
3. C. Arteaga Targeting HER1/EGFR: A molecular approach to cancer therapy Semin. Oncol. 30 3Suppl7 2003 3 14
4. T. Bader, and J. Weitzerbin Nuclear accumulation of interferon gamma Proc. Natl. Acad. Sci. USA 91 1994 11831 11835
5. B. Barre, S. Avril, and O. Coqueret Opposite regulation of myc and p21waf1 transcription by STAT3 proteins J. Biol. Chem. 278 2003 2990 2996
6. A.H. Bild, J. Turkson, and R. Jove Cytoplasmic transport of Stat3 by receptor-mediated endocytosis EMBO J. 21 2002 3255 3263
7. L. Bourguignon, K.-H. Lan, P. Singleton, S.-Y. Lin, D. Yu, and M.-C. Hung Localizing the EGF receptor - Reply Nat. Cell Biol. 4 2002 E22 E23
8. T. Bowman, M.A. Broome, D. Sinibaldi, W. Wharton, W.J. Pledger, J.M. Sedivy, R. Irby, T. Yeatman, S.A. Courtneidge, and R. Jove Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis Proc. Natl. Acad. Sci. USA 98 2001 7319 7324
9. J.F. Bromberg, M.H. Wrzeszczynska, G. Devgan, Y. Zhao, R.G. Pestell, C. Albanese, and J.E. Darnell Jr. Stat3 as an oncogene Cell 98 1999 295 303
10. Y.S. Chan, L.W. Chen, C.H. Lai, D.K. Shum, K.K. Yung, and F.X. Zhang Receptors of glutamate and neurotrophin in vestibular neuronal functions J. Biomed. Sci. 10 2003 577 587
11. T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv. Enzyme Regul. 22 1984 27 55
12. F. Cianchi, C. Cortesini, O. Fantappie, L. Messerini, N. Schiavone, A. Vannacci, S. Nistri, I. Sardi, G. Baroni, and C. Marzocca Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis Am. J. Pathol. 162 2003 793 801
13. F. Cianchi, C. Cortesini, O. Fantappie, L. Messerini, I. Sardi, N. Lasagna, F. Perna, V. Fabbroni, A. Di Felice, and G. Perigli Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer Clin. Cancer Res. 10 2004 2694 2704
14. P.J. Coffer, and W. Kruijer EGF receptor deletions define a region specifically mediating STAT transcription factor activation Biochem. Biophys. Res. Commun. 210 1995 74 81
15. S. Cohen, R.A. Fava, and S.T. Sawyer Purification and characterization of epidermal growth factor receptor/protein kinase from normal mouse liver Proc. Natl. Acad. Sci. USA 79 1982 6237 6241
16. S. Cohen, H. Ushiro, C. Stoscheck, and M. Chinkers A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles J. Biol. Chem. 257 1982 1523 1531
17. R.J. Craven, H. Lightfoot, and W.G. Cance A decade of tyrosine kinases: from gene discovery to therapeutics Surg. Oncol. 12 2003 39 49
18. B.M. Curtis, M.B. Widmer, P. deRoos, and E.E. Qwarnstrom IL-1 and its receptor are translocated to the nucleus J. Immunol. 144 1990 1295 1303
19. J.E. Darnell Jr., I.M. Kerr, and G.R. Stark Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 264 1994 1415 1421
20. A. Dowlati, D. Nethery, and J.A. Kern Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy Mol. Cancer Ther. 3 2004 459 463
21. S. Ekmekcioglu, J. Ellerhorst, C.M. Smid, V.G. Prieto, M. Munsell, A.C. Buzaid, and E.A. Grimm Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival Clin. Cancer Res. 6 2000 4768 4775
22. O. Fantappie, E. Masini, I. Sardi, L. Raimondi, D. Bani, M. Solazzo, A. Vannacci, and R. Mazzanti The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line Hepatology 35 2002 843 852
23. A. Fernandes, A.W. Hamburger, and B.I. Gerwin ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells Int. J. Cancer 83 1999 564 570
24. X.Y. Fu From PTK-STAT signaling to caspase expression and apoptosis induction Cell Death Differ. 6 1999 1201 1208
25. O. Gallo, V. Fabbroni, I. Sardi, L. Magnelli, V. Boddi, and A. Franchi Correlation between nitric oxide and cyclooxygenase-2 pathways in head and neck squamous cell carcinomas Biochem. Biophys. Res. Commun. 299 2002 517 524
26. R. Garcia, T.L. Bowman, G. Niu, H. Yu, S. Minton, C.A. Muro-Cacho, C.E. Cox, R. Falcone, R. Fairclough, and S. Parsons Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells Oncogene 20 2001 2499 2513
27. B. Grasl-Kraupp, E. Schausberger, K. Hufnagl, C. Gerner, A. Low-Baselli, W. Rossmanith, W. Parzefall, and R. Schulte-Hermann A novel mechanism for mitogenic signaling via pro-transforming growth factor alpha within hepatocyte nuclei Hepatology 35 2002 1372 1380
28. J.R. Hsiao, Y.T. Jin, S.T. Tsai, A.L. Shiau, C.L. Wu, and W.C. Su Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis Br. J. Cancer 89 2003 344 349
29. P. Hu, B. Margolis, E.Y. Skolnik, R. Lammers, A. Ullrich, and J. Schlessinger Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors Mol. Cell. Biol. 12 1992 981 990
30. L.C. Jadeski, and P.K. Lala Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors Am. J. Pathol. 155 1999 1381 1390
31. D.A. Jans, and G. Hassan Nuclear targeting by growth factors, cytokines, and their receptors: a role in signaling? Bioessays 20 1998 400 411
32. D.A. Jans, L.J. Briggs, S.E. Gustin, P. Jans, S. Ford, and I.G. Young The cytokine interleukin-5 (IL-5) effects cotransport of its receptor subunits to the nucleus in vitro FEBS Lett. 410 1997 368 372
33. D.C. Jenkins, I.G. Charles, L.L. Thomsen, D.W. Moss, L.S. Holmes, S.A. Baylis, P. Rhodes, K. Westmore, P.C. Emson, and S. Moncada Roles of nitric oxide in tumor growth Proc. Natl. Acad. Sci. USA 92 1995 4392 4396
34. R. Karni, R. Jove, and A. Levitzki Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors Oncogene 18 1999 4654 4662
35. J.D. Khoury, L.J. Medeiros, G.Z. Rassidakis, M.A. Yared, P. Tsioli, V. Leventaki, A. Schmitt-Graeff, M. Herling, H.M. Amin, and R. Lai Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma Clin. Cancer Res. 9 2003 3692 3699
36. P.K. Lala, and A. Orucevic Role of nitric oxide in tumor progression: lessons from experimental tumors Cancer Metastasis Rev. 17 1998 91 106
37. J. Larkin 3rd, H.M. Johnson, and P.S. Subramaniam Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-gamma receptor complex following activation by IFN-gamma J. Interferon Cytokine Res. 20 2000 565 576
38. S.Y. Lin, K. Makino, W. Xia, A. Matin, Y. Wen, K.Y. Kwong, L. Bourguignon, and M.C. Hung Nuclear localization of EGF receptor and its potential new role as a transcription factor Nat. Cell Biol. 3 2001 802 808
39. B. Liu, and A.H. Neufeld Activation of epidermal growth factor receptor signals induction of nitric oxide synthase-2 in human optic nerve head astrocytes in glaucomatous optic neuropathy Neurobiol. Dis. 13 2003 109 123
40. H.-W. Lo, W. Xia, Y. Wei, M. Ali-Seyed, S.F. Huang, and M.-C. Hung Novel prognostic value of nuclear EGF receptor in breast cancer Cancer Res. 65 2005 338 348
41. T.J. Lynch, D.W. Bell, R. Sordella, S. Gurubhagavatula, R.A. Okimoto, B.W. Brannigan, P.L. Harris, S.M. Haserlat, J.G. Supko, and F.G. Haluska Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N. Engl. J. Med. 350 2004 2129 2139
42. P.A. Maher Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2 J. Cell Biol. 134 1996 529 536
43. Y. Maida, S. Kyo, T. Kanaya, Z. Wang, N. Yatabe, M. Tanaka, M. Nakamura, M. Ohmichi, N. Gotoh, S. Murakami, and M. Inoue Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway Oncogene 21 2002 4071 4079
44. U. Marti, and M. Hug Acinar and cellular distribution and mRNA expression of the epidermal growth factor receptor are changed during liver regeneration J. Hepatol. 23 1995 318 327
45. U. Marti, S.J. Burwen, A. Wells, M.E. Barker, S. Huling, A.M. Feren, and A.L. Jones Localization of epidermal growth factor receptor in hepatocyte nuclei Hepatology 13 1991 15 20
46. M. Masuda, M. Suzui, R. Yasumatu, T. Nakashima, Y. Kuratomi, K. Azuma, K. Tomita, S. Komiyama, and I.B. Weinstein Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma Cancer Res. 62 2002 3351 3355
47. J. Mendelsohn, and J. Baselga Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer J. Clin. Oncol. 21 2003 2787 2799
48. K. Nakajima, Y. Yamanaka, K. Nakae, H. Kojima, M. Ichiba, N. Kiuchi, T. Kitaoka, T. Fukada, M. Hibi, and T. Hirano A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells EMBO J. 15 1996 3651 3658
49. C.Y. Ni, M.P. Murphy, T.E. Golde, and G. Carpenter gamma-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase Science 294 2001 2179 2181
50. G. Niu, K.L. Wright, M. Huang, L. Song, E. Haura, J. Turkson, S. Zhang, T. Wang, D. Sinibaldi, and D. Coppola Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis Oncogene 21 2002 2000 2008
51. M. Offterdinger, C. Schofer, K. Weipoltshammer, and T.W. Grunt c-erbB-3: a nuclear protein in mammary epithelial cells J. Cell Biol. 157 2002 929 939
52. J.G. Paez, P.A. Janne, J.C. Lee, S. Tracy, H. Greulich, S. Gabriel, P. Herman, F.J. Kaye, N. Lindeman, and T.J. Boggon EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science. 304 2004 1497 1500
53. O.K. Park, T.S. Schaefer, and D. Nathans In vitro activation of Stat3 by epidermal growth factor receptor kinase Proc. Natl. Acad. Sci. USA 93 1996 13704 13708
54. D.A. Podlecki, R.M. Smith, M. Kao, P. Tsai, T. Huecksteadt, D. Brandenburg, R.S. Lasher, L. Jarett, and J.M. Olefsky Nuclear translocation of the insulin receptor. A possible mediator of insulin's long term effects J. Biol. Chem. 262 1987 3362 3368
55. T.D. Raabe, G. Deadwyler, J.W. Varga, and G.H. Devries Localization of neuregulin isoforms and erbB receptors in myelinating glial cells Glia 45 2004 197 207
56. E.M. Rakowicz-Szulczynska, M. Herlyn, and H. Koprowski Nerve growth factor receptors in chromatin of melanoma cells, proliferating melanocytes, and colorectal carcinoma cells in vitro Cancer Res. 48 1988 7200 7206
57. V.N. Rao, and E.S. Reddy Elk-1 proteins are phosphoproteins and activators of mitogen-activated protein kinase Cancer Res. 53 1993 3449 3454
58. C.V. Rao, C. Indranie, B. Simi, P.T. Manning, J.R. Connor, and B.S. Reddy Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor Cancer Res. 62 2002 165 170
59. T. Reguly, and J.L. Wrana In or out? The dynamics of Smad nucleocytoplasmic shuttling Trends Cell Biol. 13 2003 216 220
60. J.F. Reilly, and P.A. Maher Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation J. Cell Biol. 152 2001 1307 1312
61. A. Salzman, A.G. Denenberg, I. Ueta, M. O'Connor, S.C. Linn, and C. Szabo Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers Am. J. Physiol. 270 1996 G565 G573
62. H. Shao, H.Y. Cheng, R.G. Cook, and D.J. Tweardy Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor Cancer Res. 63 2003 3923 3930
63. T. Shirogane, T. Fukada, J.M. Muller, D.T. Shima, M. Hibi, and T. Hirano Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis Immunity 11 1999 709 719
64. D. Sinibaldi, W. Wharton, J. Turkson, T. Bowman, W.J. Pledger, and R. Jove Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling Oncogene 19 2000 5419 5427
65. V. Sriuranpong, J.I. Park, P. Amornphimoltham, V. Patel, B.D. Nelkin, and J.S. Gutkind Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system Cancer Res. 63 2003 2948 2956
66. P.S. Subramaniam, and H.M. Johnson Lipid microdomains are required sites for the selective endocytosis and nuclear translocation of IFN-gamma, its receptor chain IFN-gamma receptor-1, and the phosphorylation and nuclear translocation of STAT1alpha J. Immunol. 169 2002 1959 1969
67. P.S. Subramaniam, M.M. Green, J. Larkin 3rd, B.A. Torres, and H.M. Johnson Nuclear translocation of IFN-gamma is an intrinsic requirement for its biologic activity and can be driven by a heterologous nuclear localization sequence J. Interferon Cytokine Res. 21 2001 951 959
68. J. Turkson, and R. Jove STAT proteins: novel molecular targets for cancer drug discovery Oncogene 19 2000 6613 6626
69. M. Vakkala, K. Kahlos, E. Lakari, P. Paakko, V. Kinnula, and Y. Soini Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas Clin. Cancer Res. 6 2000 2408 2416
70. S. Violot, S.S. Hong, D. Rakotobe, C. Petit, B. Gay, K. Moreau, G. Billaud, S. Priet, J. Sire, and O. Schwartz The human polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1 J. Virol. 77 2003 12507 12522
71. T. Wang, T.J. FitzGerald, and A. Haregewoin Differential expression of nitric oxide synthases in EGF-responsive mouse neural precursor cells Cell Tissue Res. 296 1999 489 497
72. S.C. Wang, H.C. Lien, W. Xia, I.F. Chen, H.W. Lo, Z. Wang, M. Ali-Seyed, D.F. Lee, G. Bartholomeusz, and F. Ou-Yang Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2 Cancer Cell 6 2004 251 261
73. M.G. Waugh, and J.J. Hsuan EGF receptors as transcription factors: ridiculous or sublime? Nat. Cell Biol. 3 2001 E209 E211
74. U.M. Wegenka, J. Buschmann, C. Lutticken, P.C. Heinrich, and F. Horn Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level Mol. Cell. Biol. 13 1993 276 288
75. D. Wei, X. Le, L. Zheng, L. Wang, J.A. Frey, A.C. Gao, Z. Peng, S. Huang, H.Q. Xiong, J.L. Abbruzzese, and K. Xie Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis Oncogene 22 2003 319 329
76. A. Wells, and U. Marti Signalling shortcuts: cell-surface receptors in the nucleus? Nat. Rev. Mol. Cell Biol. 3 2002 697 702
77. C.C. Williams, J.G. Allison, G.A. Vidal, M.E. Burow, B.S. Beckman, L. Marrero, and F.E. Jones The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone J. Cell Biol. 167 2004 469 478
78. Y. Xie, and M.C. Hung Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation Biochem. Biophys. Res. Commun. 203 1994 1589 1598
79. E. Yang, L. Lerner, D. Besser, and J.E. Darnell Jr. Independent and cooperative activation of chromosomal c-fos promoter by STAT3 J. Biol. Chem. 278 2003 15794 15799
80. C.L. Yu, D.J. Meyer, G.S. Campbell, A.C. Larner, C. Carter-Su, J. Schwartz, and R. Jove Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein Science 269 1995 81 83
81. F.X. Zhang, C.H. Lai, S.K. Lai, K.K. Yung, D.K. Shum, and Y.S. Chan Neurotrophin receptor immunostaining in the vestibular nuclei of rats Neuroreport 14 2003 851 855
82. J.C. Zwaagstra, A. Guimond, and M.D. O'Connor-McCourt Predominant intracellular localization of the type I transforming growth factor-beta receptor and increased nuclear accumulation after growth arrest Exp. Cell Res. 258 2000 121 134